Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Round 1 Of US Drug Price Negotiations Suggests Medicare Can Beat Original Part D System

Aug 15 2024

• By Sarah Karlin-Smith

close up of person putting coins into a full jar of coins — Medicare achieved a 22% net price reduction in aggerate through its first drug price negotiations. • Source: Shutterstock

Related Content

Single Product, Single Price: Medicare Will Include All Versions Of Active Ingredient For Negotiation

Mar 20 2023

Medicare Price Negotiations: Competitors’ Net Prices, Clinical Benefit Are ‘Starting Point’ For Initial Offer

Mar 16 2023

Medicare Will Pick Drugs For Negotiation Based On Gross Sales, Disadvantaging Highly-Rebated Products

Jan 13 2023

Big Rebates Already A Big Factor For Drugs On Medicare Negotiation List

Aug 29 2023

Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene?

Apr 16 2024

Medicare Negotiation Announcement: Discounts From List Price Up To 79%, But Net Savings Unclear

Aug 15 2024

Additional Topics

United States Pricing Strategies Policy Reimbursement BioPharmaceutical

More from Medicare

More from Government Payers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window